In some parts of the world, the drug companies billions of dollars of additional revenue between the global distribution of the benefits of swine flu.
Analysts predict sales of Glaxo Smith Kline, Roche and Sanofi-Aventis, the company reported the results of the first rejected the government of influenza vaccine and antiviral drugs.
Editor's Choice.
In depth: swine influenza - Pri.-28.
Health Blog Comment of swine influenza - 21 October.
Date of swine influenza - 20 July.
Hubert backlog hampers swine flu fight - July -21.
Flu warning pregnant pigs - July -19
UK braces for 100,000 of swine influenza-like event - 03 October.
Live Sales - Results from the Swiss Novartis and Baxter healthy in the U.S. vaccine may be - this is the latest game on more than 740 dead and millions of H1N1 viruses around the world.
Glaxo Smith Kline United Kingdom confirmed that it sold 150 million doses of pandemic vaccine - Influenza vaccine standard marketing season - to include all of the United Kingdom, the United States, France, Belgium and the exchange offer.
On the antiviral Relenza to GSK to reduce the duration and severity of infection and to plan the annual production of 60 million doses. Britain is to buy 10 million of the year activities.
Related to the fear of a pandemic, Roche of Switzerland, the sale of Tamiflu anti-viral drugs and the increase in orders from businesses and private citizens.
Report last week, JPMorgan Chase, the investment bank estimated that the government has ordered nearly 600 million doses of pandemic vaccine and assistance - a chemical that is added to the activities - worth $ 4.3 billion (€ 3bn, £ 2.6bn). sales and opportunities for 342m doses, worth $ 2.6bn.
She hopes that the new anti viral marketing, and sales of GSK and Roche U.S. $ 1.8bn global development and the $ 1.2bn in third world countries.
But I am not convinced of the drug production demand exceeds supply and the supply of vaccine the first consultation outbreak. Distributed through a relatively small, they can be a problem, as the choice of instructions.
They were put under pressure and additional resources, free or low-cost vaccines to third world
Analysts predict sales of Glaxo Smith Kline, Roche and Sanofi-Aventis, the company reported the results of the first rejected the government of influenza vaccine and antiviral drugs.
Editor's Choice.
In depth: swine influenza - Pri.-28.
Health Blog Comment of swine influenza - 21 October.
Date of swine influenza - 20 July.
Hubert backlog hampers swine flu fight - July -21.
Flu warning pregnant pigs - July -19
UK braces for 100,000 of swine influenza-like event - 03 October.
Live Sales - Results from the Swiss Novartis and Baxter healthy in the U.S. vaccine may be - this is the latest game on more than 740 dead and millions of H1N1 viruses around the world.
Glaxo Smith Kline United Kingdom confirmed that it sold 150 million doses of pandemic vaccine - Influenza vaccine standard marketing season - to include all of the United Kingdom, the United States, France, Belgium and the exchange offer.
On the antiviral Relenza to GSK to reduce the duration and severity of infection and to plan the annual production of 60 million doses. Britain is to buy 10 million of the year activities.
Related to the fear of a pandemic, Roche of Switzerland, the sale of Tamiflu anti-viral drugs and the increase in orders from businesses and private citizens.
Report last week, JPMorgan Chase, the investment bank estimated that the government has ordered nearly 600 million doses of pandemic vaccine and assistance - a chemical that is added to the activities - worth $ 4.3 billion (€ 3bn, £ 2.6bn). sales and opportunities for 342m doses, worth $ 2.6bn.
She hopes that the new anti viral marketing, and sales of GSK and Roche U.S. $ 1.8bn global development and the $ 1.2bn in third world countries.
But I am not convinced of the drug production demand exceeds supply and the supply of vaccine the first consultation outbreak. Distributed through a relatively small, they can be a problem, as the choice of instructions.
They were put under pressure and additional resources, free or low-cost vaccines to third world
No comments:
Post a Comment